Other
RO
RO is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Not yet recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed133%
not_yet_recruiting267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease
NCT07799428
not_yet_recruiting
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
NCT07656740
completednot_applicable
Effects of Probiotic in Treatment of Persistent Diarrhea in Children
NCT05812820
Clinical Trials (3)
Showing 3 of 3 trials
NCT07799428Not Applicable
Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease
NCT07656740
Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers
NCT05812820Not Applicable
Effects of Probiotic in Treatment of Persistent Diarrhea in Children
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3